Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Inflow
Outflow
Net flow
Funds Holding
2,770
Funds Holding Change
+14
Funds Holding Growth
+0.5%
Value
$995B
Holding in Top 10
1,277
Top 10 Change
+59
Top 10 Growth
+5%
Value Growth
+3%
New
99
Increased
1,333
Reduced
1,184
Closed
60
Capital Inflow
$33.8B
Capital Outflow
$29.1B
Net Capital Flow
+$4.74B
Capital Flow Change
+$2.89B
Calls
$11.3B
Puts
$13.3B
Net Calls
-$2.01B
Put/Call Ratio
1.18